Chemistry Outsourcing Conference Unveils 90-Speaker Conference Program to Take Place September 8-9 in New Jersey

LONG BRANCH, N.J., May 2 /PRNewswire/ -- The organizers of Pharma ChemOutsourcing Conference & Exhibition have unveiled this year's extraordinary assembly of pharmaceutical and biotech company speakers who will gather in September. Interest has reached a new peak around the exploding chemical outsourcing activities reshaping R & D and commercial manufacturing activities of the industry, reports Apaporis LLC. The conference program may be accessed via this link: http://www.chemoutsourcing.com/2008_agenda.php

Pharmaceutical outsourcing managers from Merck, Pfizer, J & J, Wyeth, and the gamut of large, mid-sized, and increasingly, biotech companies with small molecule efforts comprise the majority of attendees. Comprehensive coverage of challenges they face are discussed by industry peers in audience-interactive fashion. Topics of special interest in 2008 include:

The conference is geared around a variety of concurrent sessions on the multi-tracked program and studded with receptions, dinners, and other socializing events facilitated by the beachfront resort location on the "JerseyShore". The intimate gathering of 500-750 facilitates learning and attendee information exchange.

The 2008 keynote is:

Is The Pharmaceutical Industry Exposing Itself to Unacceptable Risk by Expanding Offshore Outsourcing?

The finest suppliers from the USA, Europe, and increasingly, India will be on hand to exhibit and network. The exhibitor list is at: http://www.chemoutsourcing.com/2008_sponsors.php

Contact Mark Alexay for more information at [email protected], 201.452.4023, or visit www.chemoutsourcing.com .

SOURCE Apaporis LLC

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.